SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron who wrote (1139)5/16/2000 10:25:00 AM
From: j_fir2  Read Replies (1) of 1386
 
I think the more marijuana and its derivatives and analogs are approved for medical use, the better off for all players, at least at this stage.

FDA APPROVES TESTING OF MARIJUANA-BASED ANTI-INFLAMMATORY DRUG
The US Food and Drug Administration (FDA) has approved Atlantic Technology Ventures' (ATV) investigational new drug (IND) application to test its synthetic marijuana derivative CT-3 as an anti-inflammatory and analgesic therapy.
pharmacotherapy.medscape.com
<a href="http://pharmacotherapy.medscape.com/21446.rhtml">Read it Here</a>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News